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Abstract
Background: Paraoxonase 1 (PON1) is an antioxidant enzyme that protects high-density lipoprotein (HDL) and low-density lipoprotein against
oxidation. Limited studies have addressed the influence of exercise on PON1 activity and its relationship with PON1 phenotypes. We investigated
relationships between PON1-192 phenotypes, PON1 activity, aerobic exercise, and blood lipid and lipoprotein concentrations in middle-aged women.
Methods: An exercise group (n = 50) engaging in regular aerobic exercise and a control group (n = 41) were selected from a subset of 300 Caucasian
women that met the inclusion criteria. SerumPON1, salt-stimulated PON1 (SSPON1), and arylesterase (ARE) activities; cholesterol levels andARE
activities of total HDL and HDL subgroups (HDLs) (supernatants obtained by polyethylene glycol); and blood lipid and lipoprotein concentrations
were determined by standardized enzymatic methods. PON1-192 QQ (low activity), QR (moderate activity), and RR (high activity) phenotype
groups were defined using serum SSPON1/ARE activity ratios. The R-carries (RC) phenotype group consisted of the QR and RR groups combined.
Results: All lipid and lipoprotein concentrations were greater in the exercise group than in the control group. Regardless of phenotype, no
significant differences were observed between the exercise and control groups in terms of serum PON1, SSPON1, or ARE activity associated with
HDLs (p > 0.05), whereas PON1 activities in QQ-phenotyped women in the exercise group were significantly higher than those in the control group
(p < 0.01), but not the RC group. A statistically significant interaction between PON1 phenotypes (QQ and RC groups) and exercise (exercise and
control groups) on PON1 activity was found.
Conclusion: These results showed that a regular aerobic exercise program can improve PON1 activity depending on PON1-192 phenotype, but not
on lipid and lipoprotein levels, in middle-aged Turkish women.
© 2016 Production and hosting by Elsevier B.V. on behalf of Shanghai University of Sport. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Atherosclerosis is the main cause of death in developed
countries. Regular aerobic exercise program reduces the risk
of developing cardiovascular disease (CVD) by increasing
serum high-density lipoprotein cholesterol (HDL-C) levels.1
Paraoxonase 1 (PON1) prevents the oxidation of both HDL and
low-density lipoprotein (LDL), impeding the development of
atherosclerosis. The anti-oxidative property of HDL has been
partly attributed to serum PON1 enzyme.2
PON1 enzyme hydrolyzes both paraoxon and phenylacetate
substrates, which are referred to in the literature as paraoxonase
and arylesterase (ARE) activities, respectively. PON1 can hydro-
lyze the oxidized lipids of LDL and HDL, which are known to
promote atherosclerosis. PON1 enzyme is produced mainly in
the liver and is released into the blood.2,3 HDL facilitates the
secretion of PON1 from the liver into the blood and stabilizes the
enzyme. PON1 is located on HDL and its subfractions (HDLs:
HDL2 and HDL3) were found in the blood.4
PON1 activity can be affected by genetic factors, life style
choices, disease status, and HDL-C levels;5 however, its activity
is mainly determined by polymorphisms in the PON1 gene. The
PON1 gene has several genetic polymorphisms, 1 set of which
occurs in codon 192 (referred to as PON1-192 polymorphisms),
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whose Q and R alleles are associated with low and high PON1
activity, respectively.6
It was reported that PON1 activity, HDL2-C, and HDL3-C are
related to CVD5–7 and that both serum PON17,8 and ARE
activities8,9 are lower in individuals with CVD than in controls.
Similarly, it was found that blood HDL-ARE activities are lower
in women with CVD than in controls and that these parameters
are more predictive for CVD than HDL-C levels.10 In addition,
ARE activity was shown to be polymorphism-independent.11
Exercise is another major factor that affects PON1
activity.9,12,13 Therefore, to protect against CVD, it is important
to monitor one’s serum PON1 and HDLs-ARE activities as well
as cholesterol levels, with the goal of improving these activities
through an appropriate exercise program.
Tomás and coworkers13 reported that acute and 4-month
exercise programs did not affect salt-stimulated PON1
(SSPON1) activity in a group of healthy Spanish men and
women athletes, regardless of PON1-192 polymorphism.
However, when PON1-192 polymorphism was considered, both
types of exercise increased SSPON1 activity, and the effects of
exercise on SSPON1 activity were modulated by PON1-192
polymorphism. Results from a separate study showed that
PON1 activity increased significantly after maximal exercise
independently of PON1-192 polymorphisms in rugby players,
but ARE activity was not affected by exercise.12 In a cross-
sectional study, blood SSPON1 and ARE activities, as well as
the distribution of PON1-192 genotypes, did not differ between
endurance athletes and controls.14 Conflicting effects of geno-
type and exercise on PON1 activity and their relationships with
PON1-192 polymorphisms were seen among athletes. More-
over, conflicting results were also observed with non-athlete
women and men with CVD.9 The reasons underlying such dis-
crepancies are unclear, as only a single study investigating the
influence of PON1-192 phenotypes on PON1 activity is found
in the literature.14
In addition, in both humans andmice, itwas shown that PON1
activity is greater in women than in men,9,15 and it was reported
that PON1 is regulated at the mRNA level in a gender-specific
manner by some pro-inflammatory and anti-inflammatory
substances.15
In parallel, it was also reported that estradiol may regulate
the specific activity and/or stability of cell surface PON1.16 In
most studies,8,9,14 blood ARE activities has been measured,
which are known to be independent of PON1-192 polymor-
phisms. Thus, ARE and PON1 measurement methods and
gender differences may influence the interpretation of results
when examining the effects of PON1-192 phenotypes.
PON1 activity varies widely between individuals within the
same genotype group and across ethnic variations.5,17 There-
fore, similar studies may yield different results with healthy
women and Turkish populations with a different ethnic group,
although no such study has been published yet.
Furthermore, it is reported that the effect of physical
activity on HDL-C concentration is related to PON1-192
polymorphisms.18 However, some studies have failed to demon-
strate associations between PON1-192 phenotype and lipopro-
tein changes,19,20 while Hegele and coworkers21 found significant
associations between PON1-192 genetic variants and plasma
HDL-C and triglyceride levels. Thus, the relationships between
PON1 phenotypes and all blood lipid and lipoprotein concentra-
tions are unclear, and these relationships have not been reported
for Turkish subjects. Our hypothesis was that a regular aerobic
exercise program can increase PON1 activity and lipid and
lipoprotein concentrations depending on PON1-192 phenotype
in middle-aged Turkish women. To test our hypothesis, we
planned this cross-sectional study to investigate the relationships
between PON1-192 phenotypes and regular aerobic exercise,
PON1 and ARE activities, and all lipid and lipoprotein concen-
trations in middle-aged women.
2. Methods
2.1. Subjects
Three hundred women volunteers completed an anamnesis
questionnaire providing information regarding their basic demo-
graphics, medical history, medication usage, frequency of
smoking and alcohol consumption, and amount of physical
activity. One hundred and sixty womenmet the inclusion criteria
and were selected for medical examination. These criteria
included (a) being ≥32 years of age and having regularmenstrual
cycles; (b) not being anemic or actively infected; (c) being free of
illnesses predisposing to CVD; (d) not being a smoker and/or an
alcohol user; (e) not taking medication affecting lipid, lipopro-
tein, or antioxidantmetabolism; and (f) agreeing to participate in
an exercise group (EG, n = 50) for 1 h for 3 days per week for at
least 3 months, involving a supervised aerobic exercise program
(step aerobics). The control group (CG, n = 41) included habitu-
ally active women (exercising less than 1 h/week) that were not
engaged in a structured training program, nor had they been so
engaged for at least 3 months prior to the study. Following
medical history inquiries, physical examinations, and blood
testing, 91 women met the inclusion criteria (Table 1).
Participants were informed about the details of the study and
the probable risks and all provided written informed consent.
The study was approved by the Ege University Medical Facul-
ty’s Ethics Committee.
2.2. Physical and physiological measurements
Physical examination consisted of anamnesis, ECG, anthro-
pometry (height, weight, and body mass index (BMI)), and
percentage of body fat (%BF). Body density and %BF values
were calculated using widely recognized equations included in
the book of Ratames and American College of Sports
Medicine.22
Physiological measurements included resting heart rate
(HR), blood pressure (BP), and maximum oxygen consumption
(VO2max). VO2max was determined by respiratory gas analysis
(Quark b2; COSMED, Rome, Italy) on a cycle ergometer
(Monark, Varberg, Sweden), using gradually increasing loads.
VO2max measurements were confirmed when 3 or more of the
following criteria were met: (1) a plateau in VO2 despite an
increase in workload, (2) a respiratory exchange ratio higher
than 1.2, (3) a peak HR at least equal to 90% of the age-
predicted maximum, and/or (4) visible exhaustion.23
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2.3. Blood sampling and analysis
Participants were instructed not to exercise, not to change
their diet, and not to take any medication or supplements for at
least 48 h prior to blood sampling. Overnight-fasting venous
blood samples were drawn between 08:30 a.m. and 10:00 a.m.
The sample-collection day was selected according to the
women’s menstrual cycles.
Blood samples were allowed to clot at 25°C for 30 min and
centrifuged at 2000 g for 10 min. Hematological analyses were
performed with a hematology analyzer (BC-3000 Plus;
Mindray, Shenzhen, China). Serum samples were stored at
−82°C until analysis. The analyses were performed within 1
month.
2.3.1. Assay of HDL, HDL2, and HDL3 supernatants (HDLs)
Supernatants of HDL and HDL3 were separated from serum
samples using polyethylene glycol (Ma: 20.000; Merck, Darm-
stadt, Germany) according to the differential precipitation
method.24 Serum baseline PON1, SSPON1, andARE activities,
as well as cholesterol and ARE activities of HDLs were ana-
lyzed on the same day by the following methods. The choles-
terol and ARE activity levels of HDL2 were estimated by
calculating the difference between HDL and HDL3.
2.3.2. Analysis of cholesterol and triglyceride levels
The cholesterol contents of HDLs (HDL-C, HDL2-C, and
HDL3-C), serum total cholesterol (TC) and serum triglycerides
(TG) levels were determined using standardized enzymatic
methods with commercial kits (Dialab GmbH, Wien, Austria)
with an autoanalyzer (Modular DP; Roche Diagnostics, Tokyo,
Japan). LDL-C was calculated as described by Friedewald
et al.25
2.3.3. Analysis of PON1 activities
Serum PON1 and SSPON1 activities were determined using
paraoxon (diethyl p-nitrophenylphosphate; Sigma Chemical
Co., St. Louis, MO, USA) as the substrate with an autoanalyzer
(Modular DP), as described previously.11,26 Paraoxon hydrolysis
rates were determined by recording the absorbance at 412 nm
and 37°C, which provided a measurement of p-nitrophenol
release. PON1 activities were measured in 800 μL assay mix-
tures containing 1 mmol/L paraoxon, 1 mmol/L CaCl2, and
5 μL of serum in 50 mmol/L Tris–HCl buffer (pH 7.4), as
described.11 One unit of paraoxonase activity was defined as
1 μmol p-nitrophenol formed per minute under the above assay
conditions.
For SSPON1 assays,26 the 800 μL assay mixture consisted of
1 mmol/L paraoxon, 1 mmol/L CaCl2, 5 μL of serum, and
1 mol/L NaCl in 50 mmol/L glycine buffer (pH 10.5). Results
are expressed as U/L for both PON1 and SSPON1. The within-
run variation constants (CVs) were <1.5% for both enzyme
assays.
2.3.4. Analysis of ARE
ARE activities associated with serum ARE and HDLs
(HDL-ARE and HDL3-ARE) were determined using
phenylacetate substrate (Merck-Schuchardt, Darmstadt,
Germany) by measuring phenol concentrations at 270 nm and
37°C with a UV–visible spectrophotometer (UV160A;
Shimadzu, Kyoto, Japan), as described previously.11 The 3 mL
assay mixture contained 1 mmol/L phenylacetate, 0.9 mmol/L
CaCl2, and 5 μL of serum in 9 mmol/L Tris–HCl buffer (pH 8).
One unit of ARE hydrolyzes 1 mmol of substrate per minute is
represented as (KU/L) of ARE. All ARE activity measurements
were performed within the same assay. Within-run variation
constants (CVs) were <5.5%.
2.3.5. Distribution of PON1-192 phenotypes
The paraoxonase phenotype distribution among the subjects
was determined using a dual-substrate (paraoxon and
phenylacetate) method.11 SSPON1/ARE activity ratios were
used to classify the phenotypes of each participant as EG, CG,
QQ (low paraoxonase activity), QR (moderate paraoxonase
activity), or RR (high paraoxonase activity) phenotypes. The
RR and QR groups together were defined as R-carriers (RC).
2.4. Statistical analyses
Data were analyzed using the SPSS program Version
15.0 (SPSS Inc., Chicago, IL, USA), following normality
Table 1
Physical and physiological features, serum lipid and lipoprotein levels, PON1,
SSPON1, and ARE activities of exercise and control groups (mean ± SD).
Parameters EG (n = 50) CG (n = 41)
Physical and physiological features
Age (year) 41.0 ± 4.3 39.5 ± 4.4
BMI (kg/m2) 25.3 ± 2.5 24.5 ± 3.6
%BF† 23.9 ± 3.2 23.8 ± 3.9
VO2max (mL/min/kg)† 24.1 ± 3.6c 18.9 ± 3.5
Resting HR (bpm) 70.8 ± 8.7b 75.0 ± 5.9
SBP (mmHg)† 118.4 ± 11.9 116.3 ± 6.7
DBP (mmHg)† 75.4 ± 9.1 73.3 ± 6.1
Serum lipid and lipoprotein levels
TC (mmol/L) 5.27 ± 0.81c 4.66 ± 0.73
LDL-C (mmol/L) 3.49 ± 0.74b 2.93 ± 0.93
HDL-C (mmol/L) 1.32 ± 0.26a 1.21 ± 0.23
TG (mmol/L)† 1.06 ± 0.57 0.91 ± 0.39
HDL2-C (mmol/L) 0.40 ± 0.17 0.37 ± 0.14
HDL3-C (mmol/L) 0.92 ± 0.16a 0.83 ± 0.20
TG/HDL-C† 0.80 ± 0.51 0.75 ± 0.38
PON1, SSPON1, and ARE activities
PON1 (U/L)† 66.9 ± 49.8 73.4 ± 59.7
SSPON1 (U/L)† 307.2 ± 210.9 373.5 ± 247.1
ARE (KU/L) 128.6 ± 36.6 121.5 ± 29.0
HDL-ARE (KU/L) 115.7 ± 25.2 109.1 ± 23.9
HDL3-ARE (KU/L) 78.8 ± 22.3 69.5 ± 25.6
HDL2-ARE (KU/L) 36.9 ± 15.0 39.7 ± 16.8
SSPON1/ARE† 2.45 ± 1.63 3.12 ± 2.11
†Variables analyzed with Mann–Whitney U test.
a p < 0.05, b p < 0.01, c p < 0.001, compared with CG.
Abbreviations: %BF = percentage of body fat; ARE = serum arylesterase
activity; BMI = body mass index; CG = control group; DBP = diastolic blood
pressure; EG = exercise group; HDL-ARE = HDL’s arylesterase activity;
HDL2-ARE = HDL2’s arylesterase activity; HDL3-ARE = HDL3’s arylesterase
activity; HDL-C = high density lipoprotein cholesterol; HDL2-C = HDL2’s
cholesterol level; HDL3-C = HDL3’s cholesterol level; HR = heart rate; LDL-
C = low density lipoprotein cholesterol; PON1 = serum paraoxonase 1 activity;
SBP = systolic blood pressure; SSPON1 = serum salt-stimulated paraoxonase 1
activity; TC = total cholesterol; TG = triglyceride; VO2max = maximum oxygen
consumption.
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(Kolmogorov–Smirnov Test) and homogeneity (Levene Test)
testing. Natural logarithmic transformation was performed on
dependent variables to normalize the non-normal data and meet
the homogeneity of variance assumption for parametric tests.
The interactions between PON1-192 phenotype and exercise
for dependent variables were assessed using a 2 × 2 (main
group × phenotype subgroups) 2-way analysis of variance
(ANOVA). One-way ANOVA with the post hoc least signifi-
cance difference (LSD) test was used to compare dependent
variables between the EG phenotype subgroups (EQQ, EQR,
ERR, and ERC) and CG phenotype subgroups (CQQ, CQR,
CRR, and CRC). Differences in the dependent variables inves-
tigated between the EG and CG were assessed by performing an
unpaired Student’s t test. In the case of non-normal distribu-
tions, nonparametric versions of the Kruskal–Wallis H test and
Mann–Whitney U test were used for statistical analysis. Depen-
dent variables analyzed with non-parametric tests were identi-
fied using the “†” symbol in the tables. Relationship levels
between the variables investigated were determined either by
calculating Pearson Product-Moment Correlation Coefficients
(raw data were used for variables having normal distributions
and log transformed data were used for variables that met the
normality assumption after log-transformation) or Spearman’s
Rank Correlation Coefficient (raw data were used for non-
normal variables).
3. Results
Participants with SSPON1/ARE ratios ≤1.93, between 2.45
and 4.89, or ≥5.48 were defined as individuals having QQ (low
activity), QR (moderate activity), or RR (high activity) pheno-
types, respectively. Thus, 46 participants (50.5% of all partici-
pants) had the QQ (low activity) phenotype, 10 (11.0%) had the
RR (high activity) phenotype, and 35 (38.5%) belonged to the
QR (moderate activity) phenotype group. The RC phenotype
group consisted of QR and RR groups combined, to obtain
statistically reliable results. The trimodal frequency distribution
of participants in this study was similar to that observed in other
Caucasian groups.1,2,27
3.1. Physical and physiological characteristics of
participants
EG and CG subjects displayed similar anthropometric char-
acteristics. The mean training experience for the EG was
3.12 ± 3.29 years. VO2max (p < 0.001) and resting HR (p < 0.01)
values were statistically different between EG and CG (Table
1). Considering phenotyping, VO2max was significantly higher in
EQQ (p < 0.001) and ERC (p < 0.001) than those in CQQ and
CRC, respectively; resting HR was significantly lower in EQQ
(p < 0.05) and ERC (p < 0.05) than those in CQQ and CRC,
respectively (Table 2).
Table 2
Serum PON1, SSPON1, ARE activities, and lipid and lipoprotein levels in exercise and control groups according to PON1-192 phenotyping (mean ± SD).
Parameters EG CG
EQQ (n = 29) EQR (n = 18) ERR (n = 3) ERC (n = 21) CQQ (n = 17) CQR (n = 17) CRR (n = 7) CRC (n = 24)
Physical and physiological features
Age (year) 41.8 ± 4.05 39.3 ± 4.54 43.0 ± 2.65b 39.8 ± 4.47 41.1 ± 4.30 39.2 ± 4.61 36.6 ± 2.51h 38.4 ± 4.23
VO2max (mL/min/kg) 24.3 ± 3.91c 23.8 ± 3.58b 23.4 ± 1.31a 23.8 ± 3.33c 18.3 ± 3.70 19.4 ± 3.70 19.5 ± 2.31 19.4 ± 3.30
Resting HR (bpm) 70.5 ± 7.91a 71.9 ± 9.84 67.3 ± 11.6 71.3 ± 9.92a 75.7 ± 5.98 74.5 ± 6.36 74.9 ± 4.81 74.6 ± 5.85
Lipid and lipoprotein levels
TC (mmol/L) 5.37 ± 0.84b 5.09 ± 0.71 5.36 ± 1.13 5.13 ± 0.76a 4.68 ± 0.62 4.77 ± 0.77 4.32 ± 0.90 4.64 ± 0.81
LDL-C (mmol/L) 3.58 ± 0.75a 3.29 ± 0.64 3.51 ± 1.32 3.32 ± 0.72 2.80 ± 1.17 3.08 ± 0.73 2.86 ± 0.78 3.01 ± 0.73
HDL-C (mmol/L) 1.30 ± 0.26 1.35 ± 0.27 1.33 ± 0.08a 1.35 ± 0.25a 1.21 ± 0.26 1.24 ± 0.23 1.09 ± 0.12 1.20 ± 0.22
TG (mmol/L) 1.08 ± 0.68 0.99 ± 0.36 1.13 ± 0.61 1.01 ± 0.39 0.86 ± 0.36 0.98 ± 0.42 0.81 ± 0.42 0.93 ± 0.42
HDL2-C (mmol/L) 0.37 ± 0.16 0.42 ± 0.18 0.53 ± 0.06a 0.44 ± 0.18 0.38 ± 0.17 0.38 ± 0.14 0.33 ± 0.09 0.36 ± 0.13
HDL3-C (mmol/L) 0.93 ± 0.16 0.93 ± 0.17 0.78 ± 0.13 0.91 ± 0.17 0.82 ± 0.23 0.86 ± 0.20 0.76 ± 0.10 0.83 ± 0.18
TG/HDL-C 0.83 ± 0.58 0.73 ± 0.33 0.85 ± 0.51 0.75 ± 0.38 0.71 ± 0.36 0.79 ± 0.42 0.74 ± 0.45 0.78 ± 0.42
PON1, SSPON1, ARE activities
PON1 (U/L) 34.7 ± 10.2b 99.6 ± 40.1d 182.0 ± 30.9d,e 111.4 ± 48.3d 23.2 ± 11.9 102.3 ± 51.2d 124.9 ± 61.5d 108.9 ± 54.1d
SSPON1 (U/L) 156.9 ± 39.6 471.8 ± 141.8d 772.0 ± 43.6d,e 514.7 ± 169.7d 133.4 ± 58.9 476.0 ± 151.4d 707.5 ± 116.2d,f 543.5 ± 176.1d
ARE (KU/L) 128.7 ± 39.3 130.0 ± 35.5 119.0 ± 15.4 128.4 ± 33.3 120.7 ± 28.3 124.9 ± 30.8 115.2 ± 29.4 122.0 ± 30.1
HDL-ARE (KU/L) 114.8 ± 27.9 119.9 ± 20.7 98.3 ± 20.1 116.8 ± 21.6 108.1 ± 26.2 108.7 ± 23.5 112.7 ± 22.5 109.9 ± 22.8
HDL3-ARE (KU/L) 79.7 ± 23.9 80.0 ± 19.6 62.4 ± 20.8 77.5 ± 20.3 64.9 ± 25.1 70.4 ± 29.1 78.5 ± 16.0 72.7 ± 25.9
HDL2-ARE (KU/L) 35.1 ± 14.3 39.9 ± 17.0 35.9 ± 7.5 39.4 ± 15.9 43.1 ± 15.8 38.4 ± 16.6 34.3 ± 20.5 37.2 ± 17.4
SSPON1/ARE 1.3 ± 0.2 3.7 ± 0.7d 6.6 ± 0.8d,f 4.1 ± 1.2d 1.1 ± 0.3 3.8 ± 0.8d 6.4 ± 1.5d,g 4.6 ± 1.6d
Note: Mann–Whitney U test was used to compare variables including non-normal data between independent groups: TG, TG/HDL-C, HR for EQR,VO2max for EQQ,
HR for ERC, all variables for ERR and CRR, HDL2-C for CQQ, HDL2-C and TG/HDL-C for CQR and CRC.
a p < 0.05, b p < 0.01, c p < 0.001, compared with same phenotypes in CG; d p < 0.001, compared with QQ within group; e p < 0.05, f p < 0.01, g p < 0.001,
compared with QR within group; h p < 0.01, compared with EQQ and CQQ.
Abbreviations: ARE = serum arylesterase activity; CG = control group; CQQ = QQ-phenotype in control group; CQR = QR-phenotype in control group;
CRC = R-carriers phenotype (QR + RR) in control group; CRR = RR-phenotype in control group; EG = exercise group; EQQ = QQ-phenotype in exercise group;
EQR = QR-phenotype in exercise group; ERC = R-carriers phenotype (QR + RR) in exercise group; ERR = RR-phenotype in exercise group; HDL-ARE = HDL’s
arylesterase activity; HDL2-ARE = HDL2’s arylesterase activity; HDL3-ARE = HDL3’s arylesterase activity; HDL-C = high density lipoprotein cholesterol;
HDL2-C = HDL2’s cholesterol level; HDL3-C = HDL3’s cholesterol level; HR = heart rate; LDL-C = low density lipoprotein cholesterol; PON1 = serum paraoxonase
1 activity; SSPON1 = serum salt-stimulated paraoxonase activity; TC = total cholesterol; TG = triglyceride; VO2max = maximum oxygen consumption.
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3.2. Measurement of all lipid and lipoprotein concentrations
HDL-C and HDL3-C (p < 0.05), TC (p < 0.001), and LDL-C
(p < 0.01) levels were significantly greater in the EG than in the
CG (Table 1). TC (p < 0.01) and LDL-C (p < 0.05) levels were
higher in EQQ phenotype group than in those of the CQQ
phenotype group. The ERC phenotype group had greater TC
(p < 0.05) and HDL-C (p < 0.05) levels, as compared to the
CRC group (Table 2). However, no differences were found in all
lipid and lipoprotein concentrations between the CQQ and CRC
phenotype groups (Table 2).
3.3. Serum PON1, SSPON1, and ARE activities
No significant difference was found between the EG and
CG in terms of serum PON1 and SSPON1 activities, ARE,
and HDLs-ARE activities (Table 1). Evaluation of the effects
of exercise according to PON1-192 phenotypes revealed that
serum PON1 activity of the EQQ group was greater than
that in the CQQ group (p < 0.01). Although HDL3-ARE
activities in the EQQ group were 23% higher than those
in the CQQ group, this difference was not statistically
significant. ARE activities were also not significantly
different among the phenotype groups (Table 2). As expected,
serum PON1 and SSPON1 levels, as well as SSPON1/ARE
ratios were significantly greater among QR, RR, and RC
phenotyped individuals than those with the QQ phenotype
(p < 0.001), with or without taking into account of exercise
status.
Two-way ANOVA showed a significant interaction
between PON1 phenotypes (QQ and RC groups) and exercise
(exercise and control groups) on PON1 enzymatic activity
(F(1, 87) = 4.01; η2 = 0.044; p = 0.048). Significant positive
correlations were found between serum PON1 and SSPON1,
SSPON1/ARE ratio, HDL3-ARE activities (p < 0.01), andHDL-
ARE activities (p < 0.05), and between HDL-C and HDL-ARE,
HDL2-C,HDL3-C (p< 0.01), HDL2-ARE,HDL3-ARE, andARE
(p < 0.05).
4. Discussion
The main finding of the present study was that serum PON1
activity in the EQQ phenotype group was greater than that in
the CQQ group (p < 0.01), but not the ERC group. Moreover,
a significant interaction was found between regular aerobic
exercise and PON1-192 phenotype on PON1, whereas no
similar interaction was found for all lipid and lipoprotein
concentrations. The results show that there are the beneficial
effects of regular aerobic exercise training on PON1 activity
and that this effect is related to PON1-192 phenotype, but not
to all lipid and lipoprotein concentrations. Although HDL3-
ARE activity was 23% greater in the EQQ group compared to
the CQQ group, this was not a statistically significant differ-
ence. This finding supports also the beneficial effects of
regular exercise on PON1 activity. No apparent PON1 pheno-
type effects on ARE activities or HDLs-ARE activities were
observed in the present study, suggesting that ARE activity is
not related to phenotype.
4.1. The effects of regular exercise on all lipid and
lipoprotein concentrations
Regardless of phenotyping, HDL-C (p < 0.05), HDL3-C
(p < 0.05), TC (p < 0.001) and LDL-C (p < 0.01) levels were
greater significantly in the EG than CG. Considering
phenotyping, while EQQ subjects had greater serum lipid and
lipoprotein concentrations than their controls, ERC subjects
had higher TC and higher HDL-C levels. In fact, exercise inten-
sity, frequency,6 duration of the exercise program, weekly exer-
cise energy expenditures surpassing 2000 kcal,27 and the need
for more vigorous physical activity compared with men28 were
found to be important factors in attaining improved lipid pro-
files in women. Therefore, exercise-linked energy expenditure
can be thought of as insufficient for improving all lipid and
lipoprotein concentrations in the present study.
It has been shown that PON1-192 QQ genotype group
members have elevated antiatherosclerotic lipid and lipoprotein
concentration profiles compared to RC in the highest tertile of
physical activity and that the effect on HDL concentration
levels is modified by PON1-192 polymorphisms.18 Similar to
previous studies,19,20 we did not observe a significant difference
in all lipid and lipoprotein concentrations between the CQQ and
CRC phenotype groups. Differences among these studies may
be mainly due to differences in the ethnic groups studied and
the frequencies of various PON1-192 polymorphisms in the
groups. The present study shows that the PON1 phenotype is
not related to any lipid and lipoprotein concentrations notwith-
standing the effects of regular exercise.
4.2. The effects of regular exercise on PON1 and ARE
activity
The beneficial effects of exercise on PON1 enzyme activities
observed in this study did not parallel the observations of Brites
et al.14 with highly trained male endurance athletes in a cross-
sectional study (the only published study similar to our own
measurement methods). Brites et al.14 did not detect any effects
of PON1 phenotype or exercise on serum PON1 and ARE
activities in men. Tomás et al.13 determined that SSPON1 activi-
ties were decreased in RC, increased in QQ homozygous youths
of both genders who trained aerobically, and that these effects
were dependent on PON1-192 polymorphisms. Another study
in athletes showed that the increase in PON1 activity following
maximal exercise does not depend on the PON1-192
polymorphism,12 in contrast to results presented by Tomás
et al.13 In addition, in a population study, Ferré et al.29 also
found that the lifestyle factors as physical activity do not play
significant role on PON1 activity except PON1-192 polymor-
phism. Although the studies by Otocka-Kmiecik et al.,12 Tomás
et al.,13 and Ferré et al.29 were polymorphism studies unlike the
present study, these results showed that the PON1-192 genotype
groups may give difference answers on PON1 activity to exer-
cise. The differences between these studies may due to differ-
ences in ethnicity, age, gender, and methods for measuring
PON1 activity in these studies.
The most significant differences found in the study were the
increased PON1 (p < 0.01) and HDL3-ARE (23%; p > 0.05)
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activities in the EQQ group, compared with their controls.
Because serum ARE activity is also used as an indicator of
PON1 enzyme protein levels,30 PON1 induction may have
played a role in the observed increases. A previous study dem-
onstrated that small HDL3 particles have greater PON1 activity
than large HDL2 particles.31 In addition, ARE activity is inde-
pendent of PON1-192 polymorphisms. Therefore, elevated
HDL3-ARE activity in the EQQ subgroup shows an improve-
ment owing to the aerobic exercise program that was indepen-
dent of the PON1 phenotype.
It has been reported that PON1 activity is related to blood
HDL-C levels.5 However, PON1 or ARE activities did not cor-
relate with HDL-C levels in the present study, and the differ-
ence in HDL-C levels between the EQQ and CQQ groups was
not significant. Therefore, our study stands in contrast to pre-
vious work and suggests that PON1 activity in the EQQ group
is unrelated to HDL-C levels. Oxidative stress can inhibit PON1
activity, whereas improvements in the antioxidant system by
regular aerobic exercise can improve PON1 activity.2,5,13,14 The
presence of greater PON1 and HDL3-ARE activity in exercise
group can also exhibit the increased antioxidant capacity by
exercise training.
A limitation of this cross-sectional study was that it only
enabled comparisons with a single environmental effect, which
was the participation in an exercise-training program of at least
3 months in duration. Thus, caution should be used in interpret-
ing results, as the starting lipid profile of the subjects might
have been biased. Nevertheless, the exclusion and inclusion
criteria imposed were designed to reduce the selection bias to
an acceptable level.
The attempt to correlate PON1 activity levels with potential
PON1-192 phenotypes through an indirect method11,26 does not
replace the need for genotyping allele frequencies, which them-
selves account for approximately half of the variation in PON1
activities. Although genotyping was beyond the scope of the
current study, analyzing the trimodal frequency distribution of
PON1 activities may be promising for future larger scale
genotype-environmental effect interaction studies.
5. Conclusion
Participation in the aerobic exercise program significantly
improved PON1 activities. The PON1-192 phenotype is related
to the beneficial effects of regular aerobic exercise on PON1
activity, but not lipid and lipoprotein levels, in middle-aged
women.
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